Early diagnosis is a prognostic factor in MEN1 patients and biochemical identification of hypergastrinemia has been shown to recognize the presence of gastrinomas before they are seen on endoscopy [32]. The gene discussed is MEN1; the disease is gastrin-producing neuroendocrine tumor.